Cleveland Clinic’s Dr. Matthew Kroh Says Cutting-Edge Endoscopic Treatments Offer Hope When Diet, Exercise or Surgery Are Not Enough
February 1st 2018, CLEVELAND and ABU DHABI: Doctors must adopt new treatments that look beyond diet, exercise and surgery if they hope to stem the Middle East’s rising obesity epidemic, a leading Cleveland Clinic surgeon said today during the Arab Health Congress 2018 in Dubai.
Dr. Matthew Kroh M.D., who is Chief of the Digestive Disease Institute at Cleveland Clinic Abu Dhabi, and has held a number of clinical and research roles at Cleveland Clinic’s main campus in the United States, says there are several innovative new endoscopic therapies now emerging, using devices placed into the stomach or intestine to help patients lose weight.
“These are new, evolving therapies that are not surgical, that target obesity and weight related diseases, that previously haven’t been widely available,” said Dr. Kroh. “They are techniques or devices that are deployed through an endoscope, which is a small tube passed through the mouth, and allows us to access the stomach and small intestine. With them we can treat obesity and weight related diseases without any incision of the abdominal wall.”
Procedures to reduce appetite include endoscopic sleeve gastroplasty, in which sutures are used to decrease the stomach size, and intra-gastric balloon placement, in which the balloon occupies space within the stomach. Each approach reduces the amount of food the patient needs to feel full, so eats less.
Other innovations include liners that decrease absorption from the small intestine, and devices that affect receptors for the hormone grehlin, which helps regulate appetite and also the distribution and rate of use of energy. Some techniques do not target weight loss, but rather focus on related disorders such as diabetes or fatty liver disease, which are part of a closely linked series of lifestyle diseases that reduce both the quality and length of life.
Dr. Kroh says the new techniques are not necessarily better than existing methods, but offer more options to tailor treatment to individual needs.
“Obesity is a spectrum, and an epidemic,” Dr. Kroh said. “On that spectrum of disease, many patients will be treated with diet and exercise, some will be treated with medications, and many will be treated effectively and long-term with surgical intervention.”
“But there are some patients that either aren’t eligible for surgery, or don’t want surgery, while diet and lifestyle changes take tremendous long-term dedication, and many will lose weight in the short term, but will then regain that weight. These new therapies target those in-between patients.”
The Arab Health Congress 2018 brings together business, leadership and clinical healthcare professionals, sharing medical knowledge, and providing the very latest updates and insights into cutting edge procedures, techniques and skills.
Cleveland Clinic has a longstanding association with Arab Health, providing Continuing Medical Education (CME) accreditation for eligible conference sessions. Cleveland Clinic physicians, both from the United States and based at Cleveland Clinic Abu Dhabi, also contribute to organizing the congress agenda, and feature prominently among the speakers for conference sessions.
